Continuous glucose monitors: New guidelines recommend expanding CGM use for people with diabetes
The latest diabetes guidelines recommend broader use of these glucose tracking devices, which show promise for reducing heart-related risks.
- Reviewed by Osama Hamdy, MD, PhD, Contributor
The latest diabetes guidelines now recommend continuous glucose monitors for many people with type 2 diabetes. The real-time data from these devices may help reduce heart-related risks in people with diabetes by helping to reduce blood sugar, cholesterol, blood pressure and body weight.
To continue reading this article, you must log in.
Source matters. Subscribe to HarvardHealthOnline+ FREE for 30 days for unlimited access to the site – where all content is reviewed by an HMS physician or faculty expert.
With HHO+ you get these exclusive benefits:
- Unlimited access to all Harvard Health Online content
- 4 expertly curated newsletters delivered monthly
- Customized website experience aligned to your health goals
- In-depth health guides on topics like sleep, exercise, and more
- Interactive features like videos and quizzes
- Members-only access to exclusive articles and resources
SPECIAL OFFER! UNLOCK EXPERT ACCESS for 30 days FREE!
Already a member? Login ».
About the Author
Julie Corliss, Executive Editor, Harvard Heart Letter
About the Reviewer
Osama Hamdy, MD, PhD, Contributor
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
